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 Lymphocyte cytosolic protein 1 (lcp1 or L-plastin) is a small actin-bundling protein that 
is typically only expressed in motile leukocytes, such as neutrophils and macrophages.  
However, it is also overexpressed in cancer cells, which may be related to tumor metastasis.  
Using CRISPR/Cas9 gene editing, our lab has created zebrafish that are genetic knockouts for 
lcp1 in order to better understand the relationship between L-plastin and cell motility. 
 Previous studies on L-plastin knockout mice have shown that the mutants have a 
decreased immune response, and therefore I predicted that our zebrafish mutants might have 
impaired development or distribution of immune cells.  Other experiments have demonstrated 
that decreasing lcp1 in tumor cells in mice decreases the growth, invasiveness, and metastasis of 
cancer cells both in vitro and in vivo.  Inducing tumors in the zebrafish mutant might show 
decreased tumor penetrance, which would further confirm the relationship between lcp1 
expression and cancer.  Finally, I investigated the entire transcriptome of the lcp1 mutant 
zebrafish embryos and compared that to the wildtype transcriptome using RNA-seq.  This 
provides information about any genes that may be differentially expressed in the mutant in order 
to compensate for the lack of lcp1 mRNA.  
Overall, this study aims to further characterize lcp1 mutant zebrafish in terms of their 
distribution of immune cells, susceptibility to tumors, as well as differences in their 
transcriptome in comparison to wildtype zebrafish.  This data can expand on the current 
knowledge of the role of lcp1 in hematopoiesis and cancer, as well as adding new understanding 






Eukaryotic cell mechanics 
 There are two types of cells: prokaryotic and eukaryotic.  Eukaryotic cells are large and 
have a cytoskeleton.  The cytoskeleton is essential for the organization of organelles within the 
cell, allows for cell movement, and connects the cell to the extracellular matrix.   Defects of the 
cytoskeleton could lead to adverse effects such as abnormal movement or morphology.  For 
example, mutations in α-actin have been linked to congenital myopathy in infants, which can 
lead to difficulty breathing or feeding (Clarkson et al. 2004). 
Components of the cytoskeleton 
The cytoskeleton has three major components: microtubules, intermediate filaments, and 
actin (Fletcher and Mullins 2010).   Each component has a specific architecture and function.  
Microtubules are long and hollow with the largest diameter, (24-25 nm), of the cytoskeletal 
molecules.  They are important for cell division as they form the mitotic spindle to organize 
chromosomes.  Intermediate filaments are slightly smaller in diameter than microtubules (8-11 
nm).  These surround the nucleus and extend to the plasma membrane.  Actin filaments are the 
thinnest cytoskeletal elements (5-9 nm), and are best known for their role in muscle contraction, 
in conjunction with myosin (Schliwa 1986). However, many proteins can bind actin for various 
functions within  eukaryotic cells (Fig. 1). 
In 1942, Bruno Ferenc Straub first recognized actin as a separate protein from myosin by 
exposing ground muscle tissue to high salt concentrations (Szent-Györgyi 2004). A short 
exposure to salt allowed the extraction of a low viscosity protein, then called ‘myosin A’, and an 
overnight exposure led to a high viscosity protein, then called ‘myosin B’.   Myosin B was 




actin was present in two forms: globular actin (G-actin) and filamentous actin (F-actin).  
However the amino acid sequence of G-actin was not confirmed until 1973, using rabbit muscle 
(Elzinga et al. 1973).   
G-actin monomers can polymerize spontaneously into F-actin filaments, although this 
process is slow due to the activation of the monomers needed to make the reaction more 
kinetically favorable (Cooper et al. 1983).  In living cells, actin polymerization is highly 
regulated, and many studies have shown the important roles of actin-polymerizing and bundling 
proteins (Paul and Pollard 2009).  These helper proteins change the structure of the cytoskeleton 
and vary by the cell type, depending on the need of the cell to expand and contract (Otto 1994).  
The modification of the actin cytoskeleton is especially important in motile cells, such as 
osteoclasts (Ma et al. 2010) and white blood cells, also known as leukocytes (Boxer et al. 1976).  
Figure 2 shows several lineages of leukocytes, including macrophages, neutrophils, T-cells, B-
cells and mast cells.  When crawling, these cells use actin-rich microspikes and/or lamellipodia 
that project from the plasma membrane (Bray 1992) (Fig. 3B).  
 
Actin-bundling proteins: the plastin family  
As stated previously, crawling cells contain actin that, when assembled and dissembled in 
the proper direction and with the correct rate, allows the cell to move in their characteristic 
motion. However, the actin must be properly bundled to carry out its function. There are many 
proteins that can bundle actin (Amos and Amos 1991), but one key group is the plastin protein 
family.   Plastins are present in all eukaryotes, and are highly conserved in sequence and function 
(Arpin et al. 1994).  In vertebrates, there are 3 family members: T-plastin, which is expressed in 




kidneys (Lin et al. 1994), and L-plastin, restricted to leukocytes (Lin et al. 1988).  Although 
expressed in different tissues, the plastin proteins share similar actin-binding domains, and share 
regulatory elements.   It is known that the ability to bind to actin is dependent upon Ca2+ (Amos 
and Amos 1991). In humans, it was found that L-plastin’s first actin-binding domain will bind to 
actin regardless of Ca2+ concentration, whereas the second actin-binding domain has a decreased 
affinity for actin in higher Ca2+ concentrations (Schwebach et al. 2017).  This confirms that Ca2+ 
is a regulatory element for the plastin proteins.  The other known regulatory element of the 
plastins is phosphorylation—specifically, phosphorylation of one or more N-terminal serines in 
the amino acid chain.  This has been investigated by Janji et al. 2006, who showed that lcp1 that 
had a Ser5Ala substitution and could not be phosphorylated reduced the protein’s localization to 
membrane extensions (Janji et al. 2006). 
L-Plastin, an immune-specific actin bundler 
 
Of the three plastin family members, two have rather broad expression (I-plastin and T-
plastin).  However the third is far more specific.  Lymphocyte cytosolic protein 1 (LCP1 or L-
plastin) was first described in 1985 when it was detected in transformed human fibroblast cell 
cultures (Goldstein et al. 1985).  LCP1 was further characterized as a leukocyte-specific 
expressed gene by cDNA analysis leukocytes (Lin et al. 1988).   Subsequently, LCP1 was 
confirmed as one of the highest expressed genes in leukocytes, regardless of myeloid or 
lymphoid branches (Hashimoto et al. 2003). 
LCP1 is a small protein (624 amino acids) that consists of two Ca2+ binding domains, two 
actin-binding domains, and a phosphorylation site at the N terminus  (Shinomiya 2012) (Fig. 
3A).   Each molecule of L-plastin can bind two adjacent actin filaments.  When one actin 




as previously mentioned (Galkin et al. 2008).  The ability of L-plastin to bind to actin is 
regulated by intracellular calcium, as previously described by Schwebach et al, 2017, and serine 
phosphorylation (Janji et al. 2006).  This was described in vivo by using wild type and LPC-1 
mutant cell lines of mice; lines that had phosphorylated LCP1 showed increased actin binding 
(Morley 2013).  
L-plastin expression and function in immune cells  
 LCP1 has a limited expression pattern, and is typically only expressed in cells of the 
leukocyte lineage, such as neutrophils (Fig. 2) (Lin, Chen, et al. 1993; Lin, Park, et al. 1993, 
1993).  Because actin is one of the most abundant proteins of the cytoskeleton, most actin-
binding proteins are present in almost all eukaryotic cells as “housekeeping genes”; however, L-
plastin is found exclusively in immune cells such as neutrophils and macrophages and is often 
used as a marker for these cell types (Mathias et al. 2009).  This suggests that L-plastin has an 
important role in immune cell function.  
 An important milestone in L-plastin research has been construction of an L-plastin 
knockout mouse (LPL -/-) (Chen et al. 2003).  Although these mice are viable and fertile, they 
are susceptible to certain infections.  For example, homozygous mutant mice and wild-type 
littermates have similar numbers of polymorphonuclear neutrophils (PMN), but mutant mice 
were unable to kill off incoming Staphylococcus aureus (Chen et al. 2003).  In vitro, cell lines 
derived from these mice showed decreased activation of SYK,	which	is	a	tyrosine	kinase 
required for the ‘respiratory burst’ needed to kill an infection such as S. aureus, in Western blots.  
Thus, it is possible that LCP1 deficiency makes neutrophils less able to combat infections.   
L-plastin deficiency has also been shown to affect other types of immune cells. The T-




responses, as shown by inflammatory response expression (Wang et al. 2010).  Furthermore, 
these LCP1 deficient mice have defects in germinal center (GC) development, which is needed 
for the long-term production of B-cells (Todd et al. 2013).   Finally, the macrophages of LCP1 
deficient mice have also been studied.  When subjected to an inhaled bacterial challenge from 
Streptococcus pneumoniae, could not clear the infection from their lung alveoli and died at 
alarming rates (~80% mortality, compared to 8% in wild types).  Using a flow cytometer for a 
marker specific to macrophages, it was determined that LCP1 deficient mice had fewer 
macrophages in the alveoli.  However, by using fluorescein- labeled bacteria, it was confirmed 
that the few macrophages that were present could ingest the bacteria.   It was concluded that the 
LPL -/- mutant macrophages are phagocytosis-competent but migration-deficient, and cannot 
reach the site of infection in sufficient numbers (Todd et al. 2016).   
Furthermore, LCP1 specifically promotes podosome longevity in relation to motility.  A 
podosome, or “foot organ”, is an adhesive cellular structure used by macrophages during 
migration.  Macrophages from wild type (WT) mice and LCP1-deficient mice were isolated and 
examined using immunohistochemistry and time-lapse microscopy in vitro (Zhou et al. 2016). In 
WT macrophages F-actin and LCP1 were co-localized in the podosomes.  LCP1-deficient 
macrophages still had podosomes, but the stability of the structure was decreased as the 
podosomes persisted for a much shorter amount of time. Overall, it is clear that LCP1 has an 
important role in mouse immune cells studied in vivo as well as in vitro.  However, there is still 






L-plastin expression and function in cancer cells 
 
As previously stated, L-plastin is typically highly restricted to normal immune cells; 
however, numerous studies have shown increased expression of L-plastin in non-immune 
derived cancer cell lines (breast, colon, kidney, etc.) and primary tumors (Fig. 4).  For example, 
Park et al. assayed twelve cancer cell lines, eight diploid human cell lines, and four transformed 
human fibroblast cell lines using Northern blotting and reverse-transcription polymerase chain 
reaction (Park et al. 1994).  Of the 48 neoplastic cell line samples tested, 92% showed some level 
of LCP1 expression, with some of the highest levels detected in hematopoietic tumors, cervical 
carcinoma and colon carcinoma.  These observations indicate that L-plastin is abnormally 
activated in cancer cells, by some unknown mechanism.  It is therefore likely that the cancer 
cells are utilizing L-plastin to bundle actin for movement, and that manipulating L-plastin can 
modify cancer cell behavior (Shinomiya 2012). 
Multiple studies have since confirmed that LCP1 expression can be used as a marker for 
primary tumors. Using cDNA samples from primary and metastatic colorectal tumors from the 
same patient, it was found that LCP1 was expressed at roughly twice as much in the metastatic 
tumor rather than the primary tumor (Otsuka et al. 2001).  Immunohistochemistry for LCP1 was 
then performed on 58 colon tumors varying from Stage II to Stage IV to better understand the 
correlation between LCP1 expression and tumor progression. LCP1 was moderately to strongly 
stained in 78.6% of Stage III and IV tumors, but only 28.5% of Stage II tumors.  This suggests 
that the expression level of LCP1 is correlated with tumor stage and could be a biomarker for 




showed that LCP1 had significant expression associated with tumor grade (p=0.035) and growth 
pattern (p=0.047). 
LCP1 can also be used as a biomarker in ovarian tumors, and has an interesting 
expression pattern.  Using matrix-associated laser desorption/ionization-mass spectrometry 
(MALDI-IMS) technology, and confirmed by Western Blot, immunofluorescence, and 
immunohistochemistry, LCP1 was found to be highly upregulated in the interface zone (IZ), or 
the region between front of the tumor invasion and the normal tissue area (Kang et al. 2010).  
This is an important observation, further confirming that LCP1 is involved in the invasion 
process.   Finally, LCP1 is highly expressed in oral squamous cell carcinomas (OSCCs).  Using 
qRT-PCR and immunoblot analysis comparing normal human oral keratinocytes to OSCC-
derived cell lines, LCP1 was significantly upregulated in the tumor cell derived lines (Koide et 
al. 2017). 
While the presence of LCP1 in multiple tumor cell types has been well described, 
additional evidence for a causal role for L-plastin in tumor metastasis and invasion comes from 
in vitro and in vivo studies that manipulate L-plastin levels.  For example, by injecting antisense 
LCP1 vectors into prostate carcinoma cell lines, Western Blots confirmed that LCP1 expression 
levels were decreased (Zheng et al. 1999).  These cells were then tested for migration and 
invasion using in vitro and in vivo assays.  In vitro, the modified cells were placed in a Matrigel 
membrane matrix and allowed 24 hours to migrate through the pores.  LCP1 knockdown cell 
lines showed 68%-89% reduction in invasiveness when compared to cancer cell lines with 
unmodified LCP1.  In vivo, nude mice were injected with the knock-down tumor lines and 21 
days after inoculation, the diaphragm of the mice was analyzed for tumors and scored for 




saw 70-80% reduction in diaphragm muscle invasion.  In addition, knocking down L-plastin in 
human melanoma cell lines using short interfering RNA (siRNA) led to reduced cell migration in 
vitro (Klemke et al. 2007). Bosseler et al. demonstrated that in multiple myeloma cell cultures 
from patients LCP1 is involved in multiple myeloma drug resistance by analyzing the expression 
level in LCP1 in drug resistant cell lines and cell lines sensitive to multiple myeloma drug 
treatments.  Drug resistant cell lines showed a higher level of LCP1 expression (Bosseler et al. 
2018).  
In vivo, a key study showed that mice injected with human prostate cancer cells that 
ectopically expressed of L-plastin increased the invasion of these tumor cells (Riplinger et al. 
2014).  Targeting LCP1 or its promoter in human bladder and ovarian cancer tumors was done 
by using an adenoviral vector with a truncated human LCP1 promoter and cytosine deaminase 
(CD). CD converts 5-fluorocytosine to 5-fluorouracil, which is toxic to most cells.  These vectors 
were injected into the human cancer cell lines, and then the cell cultures were injected into nude 
mice.  Twenty-one days after injection, mice were analyzed for tumor growth.  Compared to the 
control mice, in which 100% of the mice injected had tumors, none of the mice injected with 
LCP1 CD vector developed tumors.  This suggests that perhaps LCP1 can be used as a target for 
tumor treatment as the only cells in the body that should expression LCP1 are mature leukocytes 
and tumor cells (Peng et al. 2001). 
Overall, numerous descriptive and experimental studies have shown that L-plastin is 
abnormally expressed in cancer cells that are not derived from the immune system and that, in 
some assays, knocking down L-plastin leads to reduced cell motility, which is related to 






Zebrafish lcp1 mutants 
 Our lab has created multiple lines of zebrafish knockouts of L-plastin using 
CRISPR/Cas9 gene editing (Kell et al. 2018).   The lcp1 gene is located on chromosome 9 in the 
zebrafish genome and the induced mutations in our lines are within exon 2 of this locus (Fig. 5 A 
& B).  My work focused on the FOXTROT (FX) line of mutants, which have a net 5 base pair 
(bp) deletion, causing a premature stop codon upstream of the actin-binding domains (Fig. 5C). 
The lab has described all three mutants lines and confirmed, using Western blots, that none 
express LCP1 protein either as embryos or as adults (Fig. 6) (Kell et al. 2018).  Heterozygous 
and homozygous mutant fish can be distinguished from each other using genotyping PCR, and 
all genotypes of zebrafish are viable and can reproduce.  My work focuses on studying the 
mutants’ immune system and response to tumor-inducing plasmids to further characterize these 
fish lines. 
 
Zebrafish as a model for the innate immune system 
Although the zebrafish immune system has been studied extensively, there is no 
published research on zebrafish L-plastin mutants and their immune systems.  Unlike mice, 
zebrafish are transparent, which makes the zebrafish an ideal model organism to study immune 
cell development, migration and behavior (Traver et al. 2003; Trede et al. 2004).  Zebrafish 





 One of the earliest studies of immunity in this organism used video microscopy to show 
that, at 25 hours post fertilization (25 hpf), the bloodstream carried motile cells that had 
phagocytic capabilities (Herbomel et al. 1999).  These cells were early macrophages.  Several 
years later, researchers sought to find a screening strategy for macrophages, and they found 
through in situ hybridization that L-plastin mRNA was the best marker for this cell type, to 
differentiate them from granulocytic cell populations (Crowhurst et al. 2002).  More recently, 
another group used photoactivatable tracers in vivo live larvae to observe several lineages of 
immune cells during zebrafish development. Using an antibody against L-plastin, they 
determined that primitive macrophages and neutrophils both express this protein in fixed samples 
(Le Guyader et al. 2008). 
These investigations have shown that both neutrophils and macrophages are present in 
zebrafish at 2dpf, and both cell types express L-plastin.  However, there are no studies in 
zebrafish on the effects of knocking out this immune-specific protein. 
Zebrafish as a model for cancer 
 Zebrafish are used extensively as models for many human diseases including cancer 
initiation, progression and treatment (Lieschke and Currie 2007; Mione and Trede 2010).  
Although there have been many different approaches to induce tumors in zebrafish, the two main 
methods are chemical induction or genetic induction.  Chemically, scientists have used 
dimethylbenzanthracene to induce intestinal cancer, diethylnitrosamine to induce pancreatic 
carcinoma and N-ethyl-N-nitrosourea to induce testicular cancer (Mizgirev and Revskoy 2010; 
Mirbahai et al. 2011; Basten et al. 2013).  Using chemical models on zebrafish is attractive 
because the drugs can added to the water directly, many chemicals can be tested at once, and 




However, in order to study specific tumor types, genetically modifying the zebrafish genome is 
the most convenient option.  Although genetic modification involves constructing a plasmid with 
a human oncogene and a zebrafish promoter, then microinjecting this into the zebrafish at the 
one-cell stage, these lines can be created to model various different tumor types including 
leukemia, melanoma, and rhabdomyosarcoma (Yen et al. 2014).  With some of these cancer 
types, a fluorescent label can be used to identify the cancerous cells in vivo.  For example, the 
Langenau lab created two separate plasmids to induce rhabdomyosarcoma (RMS), a type of 
muscle cancer, and simultaneously label the RMS cells in vivo. In this system, an oncogenic 
plasmid, which induces tumors, is co-injected with a reporter plasmid, which makes the tumors 
light up (Chen and Langenau 2011).   
lcp1 zebrafish mutants as a model for transcriptional adaptation 
 Transcriptional adaptation, sometimes called genetic compensation, is the concept of a 
biological system overcoming a setback, such as non-functional protein created by 
CRISPR/Cas9, by increasing the transcription of a different gene (Grether 2005).  As described 
in a review by Darius Balciunas, this process could be one of the explanations for why a mutant 
does not have a phenotype very different from the wildtype (Balciunas 2018).  The first example 
of zebrafish transcriptional adaptation came from analyzing morphants and mutants for EGF-
like-domain, multiple 7 (egfl7) and comparing them to wildtype fish.  While the morpholino fish 
had very severe vascular defects, the mutants did not express any visible phenotype.  By 
comparing the transcriptome and proteome of the morpholinos and mutants using RNA profiling 
and qPCR, and SDS-PAGE and mass spectrometry respectively, it was found that the mutant fish 
were expressing a set of genes at an upregulated level.  Some of these genes were then injected 




Due to the lack of L-plastin in our mutants, it is possible that a related gene such as other 
isoforms of plastin or fimbrins, may have increased expression to compensate as previous studies 
on other zebrafish knockouts have described (Rossi et al. 2015).  It has also shown that LCP1 is 
expressed in the enveloping layer during gastrulation in wildtype fish, which is likely because 
the enveloping layer must crawl in a similar manner to leukocyte cells over the deep layer during 
gastrulation (Kimmel et al. 1995).  Lcp1 may be expressed for motility of these cells. However, 
our mutant zebrafish develop through gastrulation and are viable without their EVL cells 
expressing the gene. 
 
Overall, my thesis aims to study multiple characteristics of lcp1 deficient zebrafish in 
order to further understand the function of lcp1 in multiple cell types that require cell motility.   
Using these fish, I was able to investigate three things: 
1) Because L-plastin is important in immune cell function, I compared wildtype (WT) 
and mutant fish neutrophil abundance at two days post-fertilization.  My hypothesis was that the, 
mutant fish would have fewer neutrophils in the caudal hematopoietic tissue (CHT), an important 
region of immune cell development (Fig. 7)   
 2) Next, due to the increased expression levels of lcp1 in cancer cells, and the known 
correlation between this expression and the size and invasiveness of tumors, I compared the 
penetrance of rhabdomyosarcoma (RMS) in wildtype and lcp1 mutants.  I predicted that lcp1 
homozygous mutants would develop fewer or smaller tumors than wildtype fish (Fig. 8).  
3) Finally, L-plastin is also highly expressed in the enveloping layer (EVL) of the 
zebrafish during gastrulation.  It is hypothesized that this early expression of L-plastin may be 




lack of lcp1 by increasing the expression of other gene(s).  I analyzed the transcriptome of both 
wild type and homozygous mutant fish at mid-gastrula stage to determine if any genes were 
differentially expressed (Fig. 9). 
Overall, these results will further expand our knowledge of lcp1 mutant zebrafish, as well 
as lcp1’s role in hematopoiesis and cancer.  
 
Results and Discussion 
Heterozygous and homozygous mutant fish have similar numbers of neutrophils at 2 days post-
fertilization.  
L-plastin has been shown to be important in immune cells and is involving in the actin-
bundling required for leukocyte motility.  Therefore,	lack of -plastin might cause poor 
development of such cells, or inability of these cells to migrate to the proper locations.  In 
zebrafish, a specific leukocyte population, called neutrophils, occupies the caudal hematopoietic 
tissue (CHT), posterior to the yolk sac, by 2 days post-fertilization.  I therefore analyzed this 
region to quantify neutrophils in heterozygous (+/-) and homozygous mutant (-/-) fish.  
Specifically, I hypothesized that homozygous mutants would have fewer neutrophils than their 
heterozygous siblings. 
To determine if there was a difference in neutrophil number between heterozygous and 
homozygous mutants, clutches containing both genotypes were collected at 2 days post 
fertilization (dpf).  Fish were fixed at this stage, and then stained using Sudan Black, which 
reacts with the neutrophil-specific enzyme myeloperoxidase.  The result is a black precipitate in 




and image the caudal region.  Using different clutches from the same parents, I measured 21 
heterozygotes and 30 mutants in this assay overall. 
The tail areas were measured to determine if there was significant size variation between 
the two genotypes (Fig. 10B).  Because these fish are being measured in rapidly-developing 
embryos, it is possible that individuals will vary in size.  Clutches that contain both genotypes 
are the best option to use for this experiment as there will be less variation in size due to the 
embryos all being siblings, and the analysis can be done before determining the genotype in 
order to prevent bias.  To measure the stained area of the tail, I used the Photoshop quick 
selection tool for black stained neutrophils, and then optimized manually (Fig. 10C).  This input 
was measured in Image J as microns2 . 
Using an unpaired t-test, there was found to be no significant difference (p=0.668) in the 
size distribution between the two genotypes (Fig. 10C).  A similar test could be used to compare 
the stained area, representing neutrophils (Fig. 10D).  This showed that there was no significant 
difference in the amount of neutrophils stained between the two genotypes (p=0.895). 
This experiment shows that, for a large group of siblings reared together, homozygous 
mutants do not have a developmental size deficit.  Rather, they achieve larval sizes comparable 
to heterozygotes.  This result in zebrafish is similar to the mouse model of L-plastin deficiency, 
where all genotypes of these mice are viable (Chen et al. 2003).  Additionally, when measured at 
2 dpf these zebrafish mutants do not have a neutrophil deficit.  This is similar to the work with 
the lcp1 knockout mice which showed that there was no difference in the number of 
polymorphonuclear neutrophils (PMN) between wildtypes and mutants (Chen et al. 2003). 
Although this experiment measures the number of neutrophils in the different genotypes, 




motility and immune function of these neutrophils cannot be assessed.  Future studies of this 
topic might include looking at other stages of zebrafish development, other leukocyte cell types, 
neutrophil response to stimuli such as wounding, or quantifying the motility of leukocytes. 
 
Tumor penetrance between wildtype and lcp1 mutants is inconclusive 
 
L-plastin has also been shown to be expressed in tumors, and may be related to 
metastasis.  Therefore, lack of lcp1 may make mutants less susceptible to the impact of an 
inducible tumor. Induction of rhabdomyosarcoma (RMS) in the smooth muscle of zebrafish has 
already been studied and the plasmids created.  I utilized the RMS inducing plasmids to inject 
wildtype, lcp1 heterozygous, and double mutants and compare the penetrance between the 
genotypes, or the number of fish that developed tumors compared to the total number of fish 
analyzed. Specifically, I hypothesized that the double mutant fish would have a lower penetrance 
of RMS when compared to wildtype or heterozygous fish. 
In order to test if there is a difference in tumor penetrance between wildtype and mutant 
fish, I injected two plasmids, rag2:KRAS and rag2:GFP, into the fish at the one cell stage.  
Together, these plasmids should induce RMS in the smooth muscle tissue of the fish and the 
tumor cells should also be GFP+ for easy identification.  After six to eight weeks of monitoring 
after injections, the fish were euthanized and inspected for RMS tumors, which in addition to 
being GFP+ should also be visible under a dissecting scope as smooth muscle tumors should 
appear as bumps on trunk of the fish and may distort the pigmentation cells.   
The expected penetrance for wildtype fish is about 25% according to previous literature 
(Langenau et al. 2007).  The first round of wildtype injections yielded 92 fish to analyze, and one 




Hoping to get better results with follow up injections, I re-isolated and purified the plasmids 
from glycerol stocks to ensure that the DNA was as clean and intact as possible.  In addition to 
freshly isolated plasmids, the injected fish were kept in a warm incubator rather than at room 
temperature, where baby fish clutches are usually kept from 7-14 dpf before being placed on the 
running system water.  This increased temperature would hopefully allow the fish to grow faster, 
and develop more tumors.  This clutch had seventy fish to analyze, and none appeared to have 
developed tumors.  To optimize the development of tumors, I increased the concentration of 
plasmids I was injecting for the final four clutches from 30 ng/mL to 50 ng/mL and also injected 
clutches that were 1:2:1 for WT: heterozygous: mutant genotypes in order to analyze all three 
genotypes at once.  In total, 73 more fish were analyzed and only three appeared to have RMS.  
While this was an increase in penetrance when compared to the original injections, it was not 
adequate to determine if there was any significant difference between genotypes.   
To better visualize the tumors that were found, the tumor fish, as well as some “normal” 
fish from the same clutch, were sectioned for histology and stained with hematoxylin and eosin 
before being mounted and imaged.  Images were taken of the smooth muscle portion of the trunk 
area of the fish. (Fig. 11B).  The smooth muscle cells in normal fish should appear as highly 
organized circles with clearly defined edges (Fig 11C), however; the tumor fish muscle cells are 
clearly unorganized and are running in various random patterns throughout the muscle, which is 
typical for muscle tumors (Fig 11D).   
While optimization of the injections may need to be further studied, it is clear that the 
few fish that did have tumors contained muscle cells that are characteristic of RMS, and could be 
further studied for expression of GFP or lcp1.  It is likely that once optimized, the lcp1 -/- 





Possible candidates for lcp1 transcriptional adaptation in zebrafish 
As previously stated in the introduction, lcp1 mutant zebrafish are viable and reproduce 
even though lcp1 is expressed in the EVL during gastrulation (Fig 12B).  Logically, it would be 
hypothesized that knocking out an important gene in the gastrulation process would be lethal.  
Therefore, we considered that certain genes or gene families could be upregulated to compensate 
for the lack of lcp1.  Strong candidates were other genes in the plastin family, other actin-binding 
proteins, and genes linked with lcp1 in previous literature. 
Plastin family 
	
The plastin family contains 3 proteins: T-plastin, I-plastin, and L-plastin (LCP1) 
(Shinomiya 2012).  Although the structure of the plastins is highly conserved, each protein has a 
specific function and expression pattern.  While L-plastin is associated with leukocytes and 
cancer, T-plastin and I-plastin are associated with neurons and the intestines respectively 
(Shinomiya 2012). Due to the high homology between the amino acid sequences (a Clustal 
Omega alignment of the three human protein sequences gives an identity of 67.195% and 140 
similar positions) of the different proteins, it would be logical to predict that one or both of the 
other plastins may be increased in expression in our mutants to compensate for the lack of LCP1. 
 
Other cytoskeletal rearrangement genes 
	
Other options for compensation would be genes identified in previous literature 
describing the role of lcp1 in tumor cells. A study by Chaijan et al. in 2013 looked at proteins 
upregulated in invasive human cholangiocarcinoma cells in vitro when grown in basement 




addition to L-plastin, six other actin-binding proteins were found to be upregulated via Western 
blots: cytovillin 2 (ezrin), ARP3 actin-related protein 3 homolog, α-actinin-4, Adenylyl cyclase-1 
associated protein, fascin, and cofilin-1 (Chaijan et al. 2014).  Because these proteins can also 
rearrange the actin cytoskeleton and have increased expression in tumor cells similar to lcp1, it is 
possible that they could be candidates for compensation in our mutant fish.  Other actin-bundling 
proteins that are upregulated in cancer include filamin-A, formins, mena, myosin II, T-plastin, 
supervillin, and villin (Stevenson et al. 2012).  These are other genes to be looking for in the 
results of differential gene expression as they have a similar function as lcp1 (also see Fig. 1). 
Most of the proteins mentioned above are likely highly expressed in cancer cells due to 
their actin-binding qualities. Fascin, myosin, and α-actinin  (actn2 and 3 in zebrafish) are all 
fairly similar to LCP1 in structure, including actin binding domains, and all belong to general 
cytoskeletal rearrangement protein families (Winder and Ayscough 2005).  Zebrafish knockouts 
for fascin, for example, have a severe loss of filopodia in neural crest cells, which is important 
for neural crest migration (Boer et al. 2015)   Likewise, knockouts for actn2 show severe skeletal 
muscle, cardiac, and ocular defects that cannot be rescued by actn3 despite the similarity in 
sequence (Gupta et al. 2012).  These proteins could also be potential targets for gene 
compensation as they have a similar sequence and function to LCP1 
After considering candidate genes that could possibly be contributing to gene 
compensation in the lcp1 mutants, RNA-seq was used to test the possible candidates or to 
observe if genes we had not considered were being upregulated in the mutants. 
RNA-seq assumptions 
	
It is important to note that RNA-seq runs under a set of assumptions: sequenced reads 




indicate protein levels, which determine the phenotype (Jacob 2014).  We will assume that the 
assumptions hold, and will analyze the fold-changes produces by RNA-Seq as if they were valid.  
Previous methods for testing differential gene expression were qRT-PCR and microarray assays; 
however, more recent studies have shown that not only is RNA-seq as reliable as these methods, 
it is also better at detecting differentially expressed genes (DEGs) (Marioni et al. 2008; Wang et 
al. 2009; Wolff et al. 2018).  For the purposes of our experiment, the WT genotype defines the 
“normal” expression levels of each gene and any change from this in the mutant genotype could 
be an indication of compensation.   
 
 
Experimental design of whole-transcriptome analysis (RNA-seq) 
 
To test for transcriptional adaptation in mutant fish, the following experiment was 
designed.  Wild-type (WT) fish were crossed with each other to collect samples that were 100% 
WT and would serve as the baseline for gene expression in zebrafish.  lcp1 knockout (FX -/-) 
fish were also crossed with each other to collect samples that were 100% double mutants to serve 
as the experimental group.  The results from the FX samples could then be compared to the 
results from the WT samples to determine possible leads for gene compensation.  To include 
variation within a clutch, thirty embryos were homogenized to provide  each sample (Fig. 9). 
When using RNA-seq, it is also important to consider both technical and biological 
replicates.  Technical replicates are used to test the consistency of the experimental technique, 
while biological replicates are used to test for variation within a biological group.  My 




each replicate.  This design would indicate if there is extreme variation among replicates 
collected in this manner. 
Embryonic gene expression is highly dynamic.  To avoid confounding gene 
compensation with differences in developmental stage, it was essential to collect all embryos as 
stage-synchronized as possible.  Zebrafish staging was based on Kimmel et al, 1995, with Fig. 
12A serving as the reference image (Kimmel et al. 1995).   All embryos were collected at 75% 
epiboly based on visual assessment under a dissecting scope.  This stage was chosen because this 
is when lcp1 is highly expressed in the outermost cells of the enveloping layer (Fig. 12B; (Thisse 
2001; EMBL-EMI Expression Atlas  2018).  A light micrograph of a properly-staged embryo is 
shown in Fig. 12C. 
 
  In-house RNA assays 
High quality total RNA will have two distinct ribosomal bands with minimal smearing.  
Denaturing gel electrophoresis of the RNA samples showed consistently high quality, with no 
evidence of degradation (Fig. 13A).    Based on the in-house assessment, six samples of high 
quality RNA (3 WT and 3 FX -/-) were sent for processing on January 8th, 2018.  In the next 
section, I will summarize the analyses done offsite, including additional quality control, library 
construction, RNA sequencing, genomic alignment, and statistical analysis of differentially-
expressed genes (DEGs).  Additional details are provided in the Methods Section. 
External vendor RNA assays 
	
In addition to our in-house quality control, our external vendor assayed all 6 RNA 
samples for quality before sequencing (Fig. 13 B &C).  The gold standard for this procedure is 




components of each sample through micro channels and detects fluorescence of each component 
created by the gel-dye mix that is added to each sample during preparation.  The results appear 
like bands on a traditional electrophoresis gel.  These bands can be translated into peaks on a 
graph as well as a summary statistic called a RNA Integrity number (RIN).  Higher RIN scores 
indicate higher quality RNA.   For RNA-seq, a RIN number of 8 or above is preferred (Wang et 
al. 2016). 
 From the original six samples, a total of four were to be chosen for sequencing: two WT 
samples and 2 FX samples.  The four samples that had the most similar RIN scores were chosen 
in order to keep the RNA quality between samples as consistent as possible.  The four samples 
chosen were WT 1 and 2 and FX 1 and 2.  These final four final samples, representing two 
biological replicate per genotype, were then processed for RNA library construction and 
sequencing. A general flowchart of the process is shown in Fig. 14.  Additional details are given 
in the Methods section. 
Per base quality  
	
After sequencing, quality control is performed to determine the reliability of the 
sequences.  If the individual reads are not very accurate, the data cannot be used as it would yield 
inaccurate global results.  For each sample that was processed, we received a histogram of Phred 
(Phil’s Read Editor) quality scores.  Phred scores are calculated using the formula  
     Q = − 10 log10P  
where P = the probability of mis-calling a specific base (Technote 2011),  For example, a Q of 10 
has a base call accuracy of 90%, while a Q of 50 has a base call accuracy of 99.999%.  A score 




Figure 15 shows the histograms for our samples.  The X-axis is the base pair position in 
the read and the Y-axis is the Phred score.  The graph is divided into color sections representing 
the quality of the Phred score with green correlation to “good”, yellow to “fair” and red to 
“poor”.  This graph shows that all of the base pair positions in all four samples are in the green 
“good” range.  Based on these scores, we can be confident that the quality of the reads from all 
samples is accurate and the sequences can be aligned to the reference genome. 
GC content 
Another indicator of sequencing quality is GC content.  The GC content of a sequence is 
calculated as the number of G-C bases compared to all bases (including ambiguous ones).   A 
standard bell curve of GC content is expected for each sample. A high quality sample should 
have a normal distribution of GC content, with the peak being above the mean GC content of the 
genome in question (Babraham ; Risso et al. 2011). 
Figure 16 shows the GC content for the four samples.  The X-axis is the mean GC 
content percentage and the Y-axis is the number of reads.  The blue line represents the 
theoretical GC content for the zebrafish genome, and the red lines are each samples actual GC 
content percentage.  Overall, we conclude that all samples closely resemble the theoretical GC 
content and can be aligned confidently. 
Differential gene expression: between sample similarity 
	
 Distance between samples is measured via the read counts from DESeq2 after 
normalization.  These data can be used to analyze how similar or different samples are compared 
to each other (Love et al. 2014).  In Figure 17, the darker the color, the more similar the 
samples, and as the color lightens, the samples are less similar. The graph shows that the two 




FX samples are more distantly related to the wild-type samples, because these are the two groups 
being compared.  Because WT1 and WT2 were from the same WT clutch, and FX1 and FX2 
were from the same FX clutch, the results are indicative of what we would expect: samples of 




Once all the RNA fragments are sequenced and aligned, the “raw counts” are assigned to 
specific genes in the zebrafish genome.  The next step is to analyze these data for any genes that 
are differentially expressed between the samples (differentially-expressed genes = DEGs).  The 
result is shown in Figure 18 as a heat map of all of the genes in the zebrafish genome with red 
indicating genes with increased expression in the wildtype and blue showing genes with 
increased expression in the mutant.  Although this gives an overall view of the difference in 
expression between samples, it does not provide specific genes that could be compensating for 
the lack of lcp1. 
To detect which genes have unusually altered expression, a Wald test is used to measure 
the statistical significance of each comparison.  Fold-changes with a large Wald statistic, either 
positive or negative, can be considered as differentially expressed between samples.  The Wald 
statistic then generates adjusted p-values, which returns a ranked list of the top 30 differentially 
expressed genes between the two genotypes (Fig. 19).  These 30 were then clustered to identify 
genes that could be co-regulated.  This list contains a few interesting results, including some of 
genes that have yet to be described (si: dkey-101k6.5, si: ch211-197g15.9, and si: ch211-




genes were in these top 30 DEGs.  Normalized counts for these genes are shown in the  table 
below: 
Gene Name 
WT1 count WT2 count 
FX1 count 
FX2 count 
T-plastin (pls3) 683 705 810 748 
I-plastin (pls1) 27 24 19 24 
Villin (vil1) 3 5 1 0 
Fascin (fscn1b) 2 3 0 
4 
 
 The next step was to further investigate some of the genes in this list of 30 for any that 
may be of interest for future work.  To expand the scope of possible candidate genes, the entire 
list of differentially expressed genes was evaluated for any genes that were significantly 
increased in expression in mutant when compared to wildtype. 
An	expanded	view	of	specific	DEGs	
	
After investigating individual differentially expressed genes, a preliminary list of twelve 
genes was made.  These genes were chosen based on past studies, which involved cytoskeletal 
rearrangement and/or calcium dependence.  Figure 20 A shows the log2 fold change of these 
twelve genes when compared with lcp1.  Green represents the genes that have an increased 
expression in mutants, and grey represents lcp1, which is maximal in the wildtype.  The average 
normalized hit counts for these twelve genes and lcp1 are represented in darker blue (Fig, 20B) 
indicating a higher hit count, whereas white indicates  a very low hit count.  Clearly, these genes 




counts/sample  in mutants down to mlpha which had only 3 counts/sample in wildtype.  Bar 
graphs showing the normalized hit count for each sample of six selected genes are presented in 
Figure 21.  
bcl2l10 
Bcl2l10 (also called nrz), is part of the Bcl-2 family, which generally functions in 
apoptosis. However, there is some evidence that bcl2l10 may have a function in calcium 
regulated cytoskeletal rearrangement (Popgeorgiev et al. 2011).  Specifically, during 
gastrulation, bcl2l10 mutants exhibit a premature formation of the contractile actin-myosin ring, 
which may be due to increased phosphorylation of MLC (myosin light chain) by way of 
increased calcium uptake by mitochondria, which can lead to the disorganization of the 
cytoskeleton (Popgeorgiev et al. 2011).  Although this gene was not anticipated to be a possible 
candidate for transcriptional adaptation, its role in calcium-dependent cytoskeleton 
rearrangement corresponds with the similar function of LCP1. 
mid1ip1a and midip1b 
	
Similarly to bcl2l10, mutant embryos of the mid1 genes also exhibit developmental 
complications (Eno et al. 2016). These embryos have F-actin organization problems during cell 
division.   RT-PCR results indicate that mid1ip1 is present in high levels early in development, 
but then is reduced in expression as development continues (Eno, Solanki, and Pelegri 2016). 
While this protein has not yet been studied in our mutant,  perhaps the mid1ip1 expression stays 






Plekkh1, also known as max-1, is described as a neuronal guidance gene, but in zebrafish 
also functions in vascular patterning (Zhong et al. 2006).  During development, vascular 
endothelial cells migrate to form stereotypic intersegmental blood vessels (ISV).  Zhong et al. 
created two antisense morpholinos for plekkh1 in zebrafish and demonstrated that coinjection of 
both led to complete loss of the wild-type mRNA.  One day post-fertilization, injected embryos 
showed missing or misdirected ISVs, up to 5dpf.  However, the significance of this gene in lcp1 
transcriptional adaptation remains unknown. 
 
Verification of wildtype expression 
Because expression levels can vary greatly depending on the stage of development, it is 
possible that staging error during collection of the samples is skewing the results.  Figure 22 
shows the expression level of the twelve genes throughout development from the zygote to larval 
day 5.  Certain genes, such as notum1a, mid1ip1a, bcl2l10, acin1b, bnip4, and gpaa1 show little 
variation in expression around the stage collected (75% epiboly), so errors in staging would 
likely not affect the expression levels in these genes.  However, other genes are very dynamic 
around 75% epiboly, and could be at a lower level in WT samples because those samples were 




The three experiments described above help to further characterize the phenotype of the 
novel lcp1 zebrafish line.  While previous studies have looked at the immune system and cancer 




the zebrafish ortholog, and also begin to examine the transcriptome of these mutants for possible 
gene compensation. 
 Looking at the number of neutrophils between wildtype and mutants, it was hypothesized 
that mutants would have a fewer number of neutrophils due to the lack of lcp1.  However, there 
was no significant difference found between the two genotypes.  While staining with Sudan 
Black is relatively simple because the stage at which neutrophils are visible is known, zebrafish 
are transparent at that stage, and there is a specific stain for neutrophils, this experiment only 
investigates a single cell type of leukocytes, and is on fish that are no longer living.  Future 
experiments that test other leukocyte cell types, such as macrophages, may produce different 
results.  In addition, experiments that can analyze the motility and migration of leukocytes, either 
in general or as a response to a challenge, on live zebrafish may offer further insight into the 
effect of losing lcp1 expression in the organism.  
 Although fish with RMS tumors were produced, the total number of fish with tumors was 
not high enough to form any conclusions about the difference in penetrance between the two 
genotypes.  Inducing tumors by injecting at the one cell stage is fairly easy in zebrafish when 
compared to other model organisms such as mice, and RMS is an ideal solid tissue tumor as the 
presence of the cancer is easy to identify in the organisms without surgery. However, there are 
still some optimizations needed before the results that were anticipated can be produced.  Further 
experiments could be done using a different injection apparatus, continuing to modify the 
concentration of plasmids injected, and keeping the growing fish at an ideal increased 
temperature and feeding more often.  Once wildtype injections reach an ideal number of fish 




more future experiments could be done in regards to fish with tumor’s survival as well as 
analyzing the metastasis of the original tumors. 
     The generation of L-plastin mutant zebrafish that are viable and fertile allows us to 
investigate genes similar to lcp1 that may not have been known to be involved in similar 
processes.  Using RNA-seq, we have generated several leading candidates for genes that are 
upregulated in response to lack of lcp1.  While this experiment itself does not provide evidence 
of function, it is feasible in zebrafish to further test specific genes and pathways.  For example, 
future experiments can be done to confirm differences between WT and mutants including qRT-
PCR for mRNA expression levels or Western blot analysis for protein expression levels.  
Other future experiments may include creating two-locus mutants involving lcp1 and one 
or more of the genes identified here.  This would determine if knocking out both genes results in 
a lethal phenotype. 
Overall, these three experiments are a starting point in the phenotypic characterization of 
lcp1 mutant zebrafish and provide the foundation for future experiments regarding immune cell 
motility, cancer susceptibility, as well as transcriptional regulation in this organism.  It is the 
hope that this will deliver a better understanding of lcp1’s function in the body and that the 
zebrafish can act as an educator for the role of this gene. 
Methods	
General zebrafish husbandry 
 The Institutional Animal Care and Use Committee (IACUC) of DePaul University 
approved all experimental protocols.  Zebrafish were housed in the DePaul Research Support 




lights provide a 14-hour day: 10-hour night cycle. The adult diet was a 50:50 mix of finely 
ground flake food (TetraMin) and decapsulated brine shrimp eggs (American Brine Shrimp) 
once or twice a day. Adult fish were stocked at maximum density of 1 fish/200 mL. 
Zebrafish lines 
Two different zebrafish lines were used in this study.  One line was the wild type ABTU 
strain, also called WT, and the other was the FOXTROT L-plastin mutant strain also called FX. 
These lines differ in that the FX (-/-) line contains a premature stop codon that was generated 
using the CRISPR/Cas9 gene editing system (Kell et al. 2018).  When inherited in two copies,    
(-/-), these fish lack L-plastin protein as previously described (Fig. 5). 
Crossing, rearing, and larval fish care 
 
Crosses of various parental genotypes were set up for different portions of my project 
using the following protocol.    To promote spawning, one adult male and one adult female were 
placed in an off-system tank overnight, and then the fertilized embryos were collected the next 
morning with a sterile plastic strainer (Westerfield 2000). The fertilized embryos were then 
incubated at 28.5°C in a Petri dish of egg water (40 g Instant Ocean/L dI water) with one drop of 
diluted methylene blue (1:10 in egg water) for 5-7 days.  Fish to be reared were transferred to an 
off-system 1.4 L tank for an additional 5-7 days and fed live rotifers and/or a commercial food 
powder (Larval Diet, LD100; Aquatic Ecosystems).  Approximately 2 weeks after fertilization, 
larval fish were moved to the recirculating rack and received an adult diet. 
Genotyping adult fish  
Adult fish were genotyped by fin-clip to confirm the parental genotype. Each fish was 




(MS-222) diluted in approximately 500mL of system water (pH 7.4) until there was no response 
to blunt touch (Collymore et al. 2014).  The fish were then removed from the water and placed 
on a clean Petri dish.  Using a razor blade, the posterior half of the caudal fin was excised and 
placed in a labeled PCR tube.  The fin clips were then disintegrated for at least 2-3 hours at 55°C 
in 50µL lysis buffer (10 mM Tris-HCL, 50 mM KCl, 0.3% Tween-20, 0.3% Triton-X) and 1µL 
of Proteinase K, followed by a 10 minute incubation at 98°C to denature the enzyme.  The 
resulting solution was stored at -20°C.  
 For genotyping, a primer pair specific to the CRISPR-modified region of the lcp1 gene 
(FWD = 5' - TGA CCT TGT CCT GCA GAT GT - 3'; REV = 5’-CTG TTT GTG CCG TCT 
AGT GG - 3') was used to amplify the solution of 2 µL of unpurified genomic DNA and 18 µL 
of PCR reaction mix (BullsEye Taq, MidSci Scientific) according to the PCR cycle described 
follows: 10 cycles of (92°C, 20 seconds; 68-58°C, 30 seconds; 72°C, 40 seconds), 33 cycles of 
(92°C, 20 seconds; 58°C, 30 seconds, 72°C, 40 seconds), and a 72°C hold for 2 minutes. 
  
A 60 minute digestion at 55°C with 0.5 µL Bsl-1 enzyme, 1.0 µL H2O, 1.5 µL CutSmart 
buffer and 12 µL of PCR product produces distinct banding patterns for wildtype, heterozygous, 
and mutant samples.  In wild types, the diagnostic PCR product is 175 base pairs long and 
includes three (3) Bsl-1 restriction sites (5’–CCNNNNNN|GG–3’).  A complete digestion yields 
fragments of 95, 56, 24, and 1 bp, respectively, however; the 1 bp band cannot be seen and the 
24 bp band is often faint, so wild type alleles are best recognized as a doublet (95, 56bp). A 
mutant allele of LCP1 has a disrupted Bsl-1 restriction site.  After digest, this yields a band of 
approximately 151 bp (= 95 + 56) in addition to the smaller bands generated by the normal 




homozygous mutant would produce only the 151bp band.  Digested fragments were resolved on 
a 2.5% MetaPhor agarose gel in Tris-borate-EDTA (TBE) electrophoresis buffer to observe band 
differences (Fig. 10A). 
Neutrophil Staining 
Crossing and collection 
Crosses of heterozygous and homozygous FX mutants were set up and embryos collected 
the next day. The clutches from these crosses should be 50:50 heterozygous: homozygous 
mutant. These clutches are the best option to use for this experiment as there will be less 
variation in size due to the embryos all being siblings, and the analysis can be done before 
determining the genotype in order to prevent bias. 
Fixing 
 
After two days of soaking in PTU (1-phenyl-2-thiourea) to prevent pigment development, 
the embryos were fixed for 2 hours in a solution of 4% paraformaldehyde in phosphate- buffered 
saline (PF-PBS, pH 7.4), followed by rinsing in 1x PBS.  Fixed tissue was stored at 4°C in PBS 
until use. 
Staining with Sudan Black 
 
To make the Sudan Black staining solution (0.03% Sudan Black in 70% ethanol), 20 mg 
of Sudan Black powder (Electron Microscopy Services, Ca# 21610) was mixed with 100 mL of 
70% ethanol and stirred to combine.  200 uL of buffered phenol-chloroform-isoamyl alcohol 
(25:24:1) was added, and then the mixture was covered and stirred for 2 hours.  After overnight 




Fixed embryos were incubated for 30 minutes in the staining solution, then excess stain was 
washed away with three ten-minute washed of 70% ethanol.  The resulting stained embryos were 
then rehydrated in 3 ten-minute washes of (PBS + 0.1% Tween-20). 
Bisecting 
After the embryos were stained, a scalpel was used to bisect the fish between the yolk 
and the tail. The anterior portion of the fish was used for genotyping, while the posterior end was 
imaged and analyzed (Fig.7 ). 
Genotyping 
Before genotyping, the stained heads were treated in 300mM NaCl for 4 hours at 65°C.  
Samples were then genotyped in the same manner as previously described. 
 
Microscopy and image analysis  
 
Images were captured using a compound microscope and Leica imaging software.  Two images 
were collected for each specimen using the following settings: 
    Image 1:Tail Area  Image 2: Sudan Black Area 
Condenser Position  UP   UP 
Objective Lens  4x   4x 
Exposure   5.22 ms  5.22 ms 
Diaphragm   0.0   0.5 
Gain    1.0   1.0 
Saturation   1.5   1.5 
Gamma   0.59   0.59 
 
Another difference in the two images was the focus—tail area images were focused on the edge 
of the tail and Sudan Black area images were focused on the black stained cells of the specimen.  
All images included an automatic scale bar (500 microns) for area calibrations.   Finally, all 





Tail area was measured in Image J (Rasband 1997-2016).  After image calibration, the 
polygon tool was used to select an outline of the tail from the most posterior point of the yolk sac 
extension, perpendicularly across the body and around the end of the tail (Fig. 10A). The area of 
this selection was measured in square microns (m2) and exported to Excel.  
Images were adjusted in Photoshop to enhance the clarity of the stained cells as needed.  
The darkest stained pixels were manually selected, and then the selection was converted to 100% 
black.  This image was then exported to Image J for area measurement (Fig. 10B).  A Student’s 
t-test was run in Prism 7 to determine if there was any statistical significance between genotypes. 
 
Fish crossing, embryo collection and RMS injections  
Wild type incrosses, FX heterozygous incrosses were used for this portion of the study 
(Fig. 8).  Wild type crosses were used to test the protocol, as previous studies using the same 
plasmids were done on wild types and have a known penetrance (Langenau et al. 2007).  
Incrosses of FX +/- fish were used to produce clutches for injections that would be 1:2:1 +/+ : +/- 
: -/- , meaning that all possible genotypes could be observed.  Fish pairs were set up the night 
before injections with spawning barriers in the crossing tanks in order to collect eggs laid 
synchronously.  
 Plasmids were transformed into competent E. coli cells, and then grown on plates 
containing ampicillin to select for cells that contained the plasmids, which contain the gene for 
ampicillin resistance.  These colonies were then grown in LB media, and the plasmids were 
isolated and purified (Zymo Research MidiPrep kit, Ca#D4026).  Plasmids were then linearized 





 After removal of the barriers the following morning, tanks were observed every 15-20 
minutes for freshly -laid eggs.  Fertilized eggs were placed in a sterile agarose-filled Petri dish 
containing narrow trenches or slots.  Up to 120 eggs were loaded onto one plate and injected at 
the one-cell stage with 1-2 nL of plasmid DNA solution (30-50 ng/mL each of rag2: GFP and 
rag2:KRAS) 1x Danieau buffer and 1% Phenol Red.  All injections were into the yolk.  Visual 
confirmation of the injection comes from the Phenol Red, which can be seen in the yolk mass, 
and later in the dividing blastomeres. 
Fish rearing, health screening and tissue collection 
	
Injected embryos were reared as previously described (see “Husbandry”). Fish were 
monitored weekly over 4-6 weeks to ensure overall health and check for tumor development.   
On the day before tissue collection, fish were isolated from the recirculating system and placed 
overnight in clean water in a 28°C incubator without feeding.  This was done to clear the gut for 
easier visualization of tumors.  
After euthanasia in ice water, a small fin clip was taken for genotyping as described 
previously (see ‘Genotyping’). The fish were then fixed whole in 4% paraformaldehyde in 
phosphate- buffered saline (PF-PBS, pH 7.4) overnight at 4°C, followed by rinsing in 1x PBS.  
Fixed fish were then observed on a white background using a dissecting scope to survey the 
dorsal, ventral, and lateral sides for lumps, disruption in the parallel stripes along the body wall, 
or axial asymmetries, all of which can indicate a potential RMS tumor.  Suspected tumors were 
then examined under a fluorescent dissecting scope to confirm expression of GFP (Fig. 11A).  







Fixed fish that appeared to have RMS tumors were separated into head, trunk, and tail 
pieces using a scalpel.  The tissue fragments were then placed in an acid-EDTA decalcifying 
solution (Cal-Ex, Fisher Scientific) overnight at 4°C.   Decalcified samples were then washed in 
1x PBS and dehydrated in an ethanol series up to 100% anhydrous EtOH.  Samples were then 
washed 3x 30 minutes in amyl acetate, which serves as a bridge between the ethanol and the 
molten paraffin used for embedding. 
 
Specimens were passed through 3 changes of melted paraffin (58-6°C for 30 minutes 
each), then placed in warm vacuum cabinet to remove excess air.  Molds were sprayed with mold 
release, and then a small amount of wax was added to the bottom of the molds and cooled until 
sticky.  Tissue fragments could then be placed into mold and oriented in the desired manner 
before filling the mold with wax and allowing it to set overnight.  Embedded samples were 
unmolded the next day and stored in a dust free container at room temperature until sectioning. 
 
 
Paraffin blocks were sectioned at 10 microns using a manual rotary microtome 
(American Optical 820).  Cut sections were floated on warm distilled water, then mounted on 
coated glass slides (Colorfrost Plus, Fisher Scientific). Slides were then dried overnight at room 
temperature under a dust cover.  Hematoxylin and eosin staining was applied using the following 
protocol: 2 rounds of Citrasolv (Fisher brand, Ca# 04-355-121), 1 minute; series of 100%, 95%, 
70%, and 50% ethanol for 1 minute; dI water, 1 minute; hematoxylin (Electron Microscopy 




seconds; dI water, 1 minute; eosin (Electron Microscopy Sciences, Ca# 26762-01), <10 seconds; 
95% and then 100% ethanol, 1 minute; 2 rounds of Citrasolv, 1 minute.  
 Once stained, coverslips were mounted onto slides using DPX mounting medium (Sigma 
Aldrich) and set flat overnight to dry.  
 
Embryo collection and genotyping for RNA-seq  
	
Genotyped males and females were paired to produce 100% wild type or 100% 
homozygous mutant embryos (FX -/-), respectively.   Embryos were incubated in a Petri dish at 
28°C for 5-6 hours until 70 epiboly.  A single RNA sample was obtained by placing 30 embryos 
from the same clutch into a 1.5mL Eppendorf tube for collection.  300µL of TRI-zol reagent was 
added and embryos were then homogenized for 10-15 seconds using a motorized micropestle.  
Homogenates were stored at -80°C until RNA extraction. 
To confirm the genotype of each clutch (100% WT or 100% FX -/-), eight embryos per 
clutch were also collected in individual PCR tubes and genotyped as previously described (see 
‘genotyping’). Once the genotype of the samples was confirmed, RNA could be isolated and 
purified. 
RNA isolation and purification 
 
Total RNA was extracted and purified using the Direct-zol RNA MiniPrep kit (Zymo 
Research R2070) following the manufacturer’s instructions.  Briefly, the RNA samples were 
thawed on ice, an equal volume of 100% ethanol was added, and the samples were then vortexed 
and spun down. The mixture was then transferred to a spin column in a collection tube and 
centrifuged at 14,000 rpm for 1 minute with flow through discarded.  Columns were then washed 




75µL of DNA digestion buffer) at room temperature for 15 minutes.  This step ensures that no 
genomic DNA contaminates the RNA samples. The columns were then washed with RNA 
PreWash, RNA Wash Buffer, and finally eluted in 50µL of nuclease-free water.  Purified RNA 
was stored at -80°C until samples were tested for quality control.  
RNA quality control 
In house assays 
 
RNA concentration and purity were confirmed using two in-house methods: 
spectrophotometry and agarose gel electrophoresis.  Sample concentration was assessed using a 
Nanodrop 2000c to measure the 260 nm /280 nm absorbance ratio.  Purity was assessed using the 
260 nm /230 nm absorbance ratio to confirm that the sample was free from contamination from 
extraction reagents or other contaminants.  If samples had a concentration and purity ratios that 
exceeded the requirements of the sequencing vendor (concentration >50 ng/ µL, A260/280=1.8-
2.2), they were further examined for RNA quality on a denaturing agarose gel.   
Denaturing gel analysis of total RNA 
A small portion of each RNA sample (approximately 300ng of RNA) was added to RNA 
loading dye (New England Biolabs, #B0363A) and heated at 70°C for 10 minutes to denature.  
The denatured RNA was placed on ice for 1-3 minutes, then run on a fresh 1% lithium boride 
agarose gel with a DNA size marker (Hi-Lo Marker, Bionexus).  Electrophoresis was at 220V 





External vendor library preparation and sequencing 
Total RNA was reverse-transcribed to cDNA for stability, and fragmented to 200-500 bp 
using either DNase I treatment or sonication.  Next, the RNA fragments were tagged with 
adapters (Wang, Gerstein, and Snyder 2009).  Adapters are short oligonucleotides used as 
sample-specific “barcodes”.  The cDNA fragments in each sample are given a specific adapter 
sequence to identify the reads specific to that sample.  This allows for all of the samples to be run 
in one sequencing lane, and eliminates the need for technical replicates because all samples are 
being run on the same machine, in the same lane, and at the same time (Schiemer 2011). 
 
 The fragments are then sequenced using an Illumina sequencer.  The Illumina sequencer 
uses fluorescent bases to determine the sequence of each fragment via complementation (Quail et 
al. 2012). Typically, 30 million reads is needed to capture most of the expressed genes in sample 
for differential gene expression analysis (Korpelainen et al. 2015).  If all of the samples have 
over 30 million sequenced reads, this means that the samples have a high enough read number to 
move forward with bioinformatics analysis. Reads were as follows: WT1 and 2 = >34 million, 
FX 1 and 2 = >32 million.  
 
Aligning sequenced reads to the genome. 
	
After RNA is sequenced, fragments were aligned to the zebrafish reference genome using 
the program Spliced Transcripts Alignment to a Reference (STAR) (Dobin et al. 2013). This 
program analyzes each fragment, or read, to assign it a specific genomic location. STAR is 
unique compared to other alignment programs because it will find the longest portion of a 




of the genome close by.  For example, the first part of the fragment may correspond to exon 3 of 
a gene, and the rest of the fragment corresponds to exon 4.  STAR ensures that the portion 
corresponding to exon 4 is analyzed first in order to prevent mismatches to other unrelated 
portions of the genome.  This then results in data for the number of “hits” for the 5’ and 3’ 
untranslated region (UTR), and various exons for each gene.  
 
Differential gene expression 
 The bioinformatics of differential gene expression was performed with the program, 
DESeq2, which uses the negative binomial test on variance estimated (Love, Huber, and Anders 
2014). DESeq2 can be run in R/BioConductor and the package is freely available (Love, Huber, 
and Anders 2014).  
DESeq2 uses a count matrix, K, with one row for each gene, i, and one column for each 
sample, j. Read counts K ij can be modeled using a negative binomial distribution with mean, µ ij, 
and dispersion, αi..  This process essentially takes the raw count data from STAR and normalizes 
it into read counts that can be used to analyze similarities or differences in gene expression 
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Figure 1:Actin-binding Proteins  
 
The figure shows various proteins that can bind actin for specific functions.  
Image Source: Actin-binding proteins, Steven J. Winder, Kathryn R. Ayscough, Journal of Cell Science 2005 118: 







Figure 2: Lineage hierarchy of blood and immune cells.  
 
White blood cells, or leukocytes, all express lcp1 and are derived from pluripotent blood stem cells. However, other 
cell types derived from these same stem cells, such as red blood cells and platelets, do not express lcp1. Image 





Figure 3:  Structure and function of L-plastin, a cytoplasmic actin-bundling protein. 
 
A) L-plastin binds to filamentous actin and creates bundles within the cytoplasm.  Image Source: (Kell et al., 2018).  
B) Rearrangement of the cytoskeleton allows for the motility of cells via lamellipodia and filopodia.   Image Source: 








Figure 4: Immunohistochemical staining for L-plastin protein in four human tumors.  
 
Sections were stained for LCP1 using antibody HPA019493 or CAB020673, followed by secondaries and 
DAB substrate (give a bit more detail here).  Brown cells = L-plastin (+) cells; blue = hematoxylin-






Figure 5:  Genetic engineering of lcp1 mutant zebrafish. 
A) Location of L-plastin on zebrafish chromosome 9 and exon-intron structure of the locus. The most 5’ and 
3’exons are untranslated (5’ and 3’ UTR) flank the coding exons (#1-15).  B) Schematic of the CRISPR/Cas9 target 
site within exon 2. The exon 2 guide RNA (purple) binds the complementary genomic DNA (black) and docks with 
the Cas9 nuclease (gray). Upstream of the protospacer-adjacent motif (PAM, in orange), the Cas9 cleavage site 
targets a Bsl1restriction site (yellow), causing indels. C) Alignment of wild type and edited alleles of zebrafish lcp1. 
CH= ‘Charlie’, a 5 bp deletion; LM= ‘Lima”, a 7-bp deletion; FX= ‘Foxtrot’, a net 5 bp deletion.  Image Source: 







Figure 6: LCP1 protein is undetectable in null embryos and adults.  
 
A) Chemiluminescent Western blot comparing 2 days post-fertilization (dpf) total protein lysates from a wild 
type line (WT) and three independent lcp-1 null lines (CH, FX and LM). The top panel shows LCP1 signal 
(~65kDa) and the middle panel shows actin signal(~43kDa), a positive control. The bottom panel reflects the 
total protein in each lane (Coomassie Blue stain).   
 
B)  Chemiluminescent Western blot comparing total protein lysates from 5 adult animals of one line (CH): two 









Figure 7:  Procedure for staining larval neutrophils with Sudan Black.   
 
A) FX heterozygotes (+/-) and homozygous mutants (-/-) are crossed to produce a clutch that is 1:1 (+/-) 
and (-/-) progeny.  B) After development for 2 days, fish are euthanized, fixed and neutrophils stained 
with Sudan Black. C) Bisected fish are genotyped (head) and imaged (tail) to record the density of 





Figure 8:  Procedure for inducing rhabdomyosarcomas (RMS) in zebrafish.  
 
 A) Brief plasmid maps of rag2:KRAS and rag2:GFP where red = the rag2 promoter site, yellow = 
ampicillin resistance, blue = the human KRAS oncogene and green = the GFP genes. B-C) Fish of the 
desired genotype (WT = wild type; FX = Foxtrot mutant) were crossed and offspring collected. D) At the 
1-2 cell stage, zygotes were co-injected with one oncogenic plasmid (rag2:KRAS) and one reporter 
plasmid (rag2:GFP) . E) After 4-6 weeks of monitoring, some percentage of fish are predicted to develop 






Figure 9: Procedure for analyzing the transciptome of wild type and L-plastin mutant embryos.  
 
 A)  Fish of the desired genotype (WT = wild type; FX = Foxtrot mutant) were crossed and offspring 
collected. B) Once embryos reached 75% epiboly, three cohorts of 30 embryos per clutch were 
homogenized in TRI-zol reagent.  C) Total RNA was evaluated by gel electrophoresis and 








Figure 10. Neutrophil staining results. 
 
A) Representative genotyping gel of 1 dpf embryos shows that the clutches are 50:50 for 
heterozygous (+/-) : homozygous mutant (-/-) genotypes 
 
B) A tail area measurement in ImageJ.  Blue line = area measured. 
 
C). A Sudan Black-stained tail, showing the distinctly dark neutrophils.  
 
D). Dot plot of the distribution of tail areas.  
 






Figure 11. RMS tumor induction results. 
 
A) Comparison of an RMS+ tumor fish and a normal sibling .  The bright field image is overlaid with a 
fluorescent image of the same specimens. B) Cartoon of the anatomy of the zebrafish trunk. Longitudinal 
diagram of 48 hpf zebrafish embryo, with neural tube (NT, green), notochord (N, turquoise), posterior 
cardinal vein (PCV, dark blue), dorsal aorta (DA, red), intersegmental vessels (ISVs, dark blue and red 
according to origin), muscle blocks (M, pink) and yolk tube (YT, yellow). Image Source: doi: 
10.1371/journal.pone.0007716.  C-F)  H&E-stained cross sections of zebrafish trunk tissue.  Images were 
taken from roughly the same position as the black box in panel B.  C&E.  Normal muscle histology.  D & 






Figure 12. Staging of the zebrafish embryo at 75% epiboly. 
 
A) Staging table diagram of 75% epiboly (Kimmel et al. 1995). 
 
B) in situ hybridization for lcp1 mRNA at the same stage.  EVL = enveloping layer (Source:  
Thisse et al, ZFIN).  
 






Figure 13. Quality control of zebrafish RNA samples. 
 
A) An in-house RNA denaturing gel indicating that both large and small subunits of rRNA are 
present in roughly equal ratios, and that RNA has not degraded. 
B) External quality control using the Agilent 2100 Bioanalyzer.  






Figure 14. Workflow of RNA-seq analysis. (Source = Genewiz NGS) 
A-D) Steps in cDNA library preparation prior to deep sequencing. 







Figure 15. Quality scores for the accuracy of base calls. 
Each panel plots position of read on the X axis and quality score on the Y axis.  The yellow 
points indicate the accuracy of the base assignments in each of the four samples processed for 
sequencing. All samples have high quality, within the green zone.  







Figure 16. GC content of all samples. 
 
Each panel plots percentage of CG content on the X-axis and number of reads for each 
percentage on the Y-axis.  The blue line is the theoretical distribution for zebrafish and the red 
line is the actual distribution for each sample.  All samples closely follow the theoretical standard 
bell curve of GC content. 








Figure 17.  Transcriptomic similarity between samples. 
 
Based on all mapped read counts after normalization, the darker the color, the more similar the 
samples. A score of zero (0) would indicate no differences and identical samples. 






Figure 18.  Heat map of differential gene expression for all four mRNA samples.  
 
Each row represents a known genes in the zebrafish genome (N total = 29292). Red indicates a 
high expression level, while blue indicates a lower expression level, relative to the average 







Figure 19. Heat map of the top 30 differentially expressed genes (DEGs) between samples. 
 
A two-way cluster analysis of the top 30 differentially expressed genes (DEGs) based on 
adjusted p-values from DESeq2. Left to right, samples are clustered by overall similarity.  Top to 
bottom, DEGs are clustered based on possible co-regulation.  Darker blue indicates lower 






Figure 20. Detailed expression data for twelve genes of interest. 
 
A) A visual representation of the log2 fold change (log2 FC) between wildtype and mutant 
samples for twelve genes of interest. Green bars = greater expression in mutant, Gray bar = 
greater expression in WT. B) Normalized count data averaged between the biological replicates 
for the same twelve genes.    Dark blue indicates high-count transcripts (abundant); white 






Figure 21. Bar graphs of normalized counts for six genes of interest.  Bar graphs were 
created based on normalized hit counts for each sample and genes were chosen based on highly 
significant Wald statistics. From upper left to lower right, genes are ranked from abundant to 
rare.  The complete gene names are given here: 
acin1   apoptosis chromatin condenser inducer  
bcl2l10 BCL2-like 10  
bnip4  BCL2 interacting protein 4  
mid1ip1a MID1 interacting protein 1a   
mid1ip1b MID1 interacting protein 1b  





Figure 22. Known expression levels of specific candidate genes during zebrafish 
development. 
 
WT expression levels of genes of interest over four developmental stages. The darker the color, 
the higher the expression level TPM = transcripts per million (Data Source:  EMBL-EBI 
Expression Atlas).  
	
